The biotech industry is well-positioned for steady growth, owing to rapid advancements in drug developments and the growing impact of chronic diseases. Given the industry’s solid long-term growth prospects, quality biotech stocks - Organogenesis Holdings Inc. (ORGO), Innoviva, Inc. (INVA), and Amgen Inc. (AMGN) could be wise additions to your portfolio this month.
Before diving deeper into their fundamentals, let’s discuss why the biotech industry is well-positioned for growth.
